Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- SCIENTIFIC REPORTS6 · 2016
- 피인용
- Web of Science 45
- JCR IF
- JCR 2015 5.228
- ISSN
- 2045-2322
저자
- 손범석제1저자부산대학교, 자연과학대학, 생명과학과, KO
- Jun, Se YoungWashington State Univ, Dept Chem, US
- 서현정부산대학교, 대학원, 생명시스템학과, KO
- 윤혜숙부산대학교, Dept Integrat Biosci & Biotechnol, KO
- 양희정부산대학교, 자연과학대학, 생명과학과, KO
- 김완연부산대학교, 자연과학대학, 생명과학과, KO
- 김형국부산대학교, 나노과학기술대학, 나노에너지공학과, KO
- Kang, ChulHeeWashington State Univ, Dept Chem, US
- 윤부현교신저자부산대학교, 자연과학대학, 생명과학과, KO
초록
Increased survival of cancer cells mediated by high levels of ionizing radiation (IR) reduces the effectiveness of radiation therapy for non-small cell lung cancer (NSCLC). In the present study, danshensu which is a selected component of traditional oriental medicine (TOM) compound was found to reduce the radioresistance of NSCLC by inhibiting the nuclear factor-kappa B (NF-kappa B) pathway. Of the various TOM compounds reported to inhibit the IR activation of NF-kappa B, danshensu was chosen as a final candidate based on the results of structural comparisons with human metabolites and monoamine oxidase B (MAOB) was identified as the putative target enzyme. Danshensu decreased the activation of NF-kappa B by inhibiting MAOB activity in A549 and NCI-H1299 NSCLC cells. Moreover, it suppressed IR-induced epithelial-to-mesenchymal transition, expressions of NF-kappa B-regulated prosurvival and proinflammatory genes, and in vivo radioresistance of mouse xenograft models. Taken together, this study shows that danshensu significantly reduces MAOB activity and attenuates NF-kappa B signaling to elicit the radiosensitization of NSCLC.
키워드
NF-KAPPA-BEPITHELIAL-MESENCHYMAL TRANSITIONIONIZING-RADIATIONINDUCE RADIOSENSITIZATIONTYROSINE PHOSPHORYLATIONSALVIA-MILTIORRHIZAPREVENTS APOPTOSISCHINESE MEDICINEDRUG TARGETEXPRESSION
식별자
- WoS UID
- 000370743600001



로그인
연구물 목록으로